Integration of IMRT and brachytherapy

Image-Guided IMRT

Volumn , Issue , 2006, Pages 423-437

  Williamson, Jeffrey F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874978186     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-30356-1_33     Document Type: Chapter

References (77)

1. vant Riet A, Mak ACA, Moerland MA, Elders LH, van der Zee W (1997) A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 37:731-736
2. Zelefsky M, Fuks Z, Happersett L, Lee H, Ling C, Burman C, Hunt M, Venkatraman E, Jackson A, Leibel S (1999) Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patientswith prostate cancer. Int J Radiat Oncol Biol Phys 45(Suppl 1):170
3. Bel A, van Herk M, Lebesque JV (1996) Target margins for random geometrical treatment uncertainties in conformal radiotherapy. Med Phys 23:1537-1545
4. de Boer JC,Heijmen BJ (2002)Anew approach to off-line setup corrections: combining safety with minimum workload. Med Phys 29:1998-2012
5. Meijer GJ, Rasch C, Remeijer P, Lebesque JV (2003) Threedimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 55:1277-1287
6. Stroom JC, de Boer HC, Huizenga H, Visser AG (1999) Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability Int J Radiat Oncol Biol Phys 43:905-919
7. VanHerk M(2004) Errors and margins in radiotherapy. Semin Radiat Oncol 14:52-64
8. Yan D, Ziaja E, Jaffray D,Wong J, Brabbins D, Vicini F,Martinez A (1998) The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. Int J Radiat Oncol Biol Phys 41:715-720
9. Langen KM, Jones DTL (2001) Organ motion and its management. Inter J Radiat Oncol Biol Phys 50:265-278
10. ICRU (1993) Prescribing, recording, and reporting photon beam therapy. Report No 50, International Commission on Radiation Units and Measurements
11. ICRU (1999) Prescribing, recording, and reporting photon beam therapy (supplement to ICRU Report No 50). Report No 62, International Commission on Radiation Units and Measurements
12. vanHerkM,RemeijerP, Rasch C,Lebesque JV(2000)Theprobability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy Int J Radiat Oncol Biol Phys 47:1121-1135
13. Van de Steene J, Van denHeuvel F, Bel A,Verellen D,DeMey J, Noppen M, De Beukeleer M, Storme G (1998) Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation. Int J Radiat Oncol Biol Phys 40:967-976
14. Bel A,Vos PH, Rodrigus PT, Creutzberg CL, Visser AG, Stroom JC, Lebesque JV (1996) High-precision prostate cancer irradiation by clinical application of an offline patient setup verificationprocedure, usingportalimaging. Int J RadiatOncol Biol Phys 35:321-332
15. Yan D, Lockman D, Brabbins D, Tyburski L,Martinez A (2000) An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48:289-302
16. Shiu AS, Chang EL, Ye JS, Lii M, Rhines LD, Mendel E, Weinberg J, Singh S, Maor MH, Mohan R, Cox JD (2003) Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys 57:605-613
17. JaffrayDA, Siewerdsen JH,Wong JW,Martinez AA (2002) Flatpanel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 53:1337-1349
18. ICRU (1997) Dose and volume specification for reporting interstitial therapy. Report No 58, International Commission on Radiation Units and Measurements
19. Roberson PL, Narayana V, McShan DL, Winfield RJ, McLaughlin PW (1997) Source placement error for permanent implant of the prostate. Med Phys 24:251-257
20. Yu Y, Waterman FM, Suntharalingam N, Schulsinger A (1996) Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. Int J Radiat Oncol Biol Phys 34:717-725
21. Taschereau R, Roy J, Pouliot J (1999) Monte Carlo simulations of prostate implants to improve dosimetry and compare planning methods. Med Phys 26:1952-1959
22. Merrick GS, Butler WM, Dorsey AT, Lief JH (1999) Potential role of various dosimetric quality indicators in prostate brachytherapy. Int J Radiat Oncol Biol Phys 44:717-724
23. McLaughlin PW, Narayana V, Drake DG, Miller BM,Marsh L, Chan J, Gonda R Jr, Winfield RJ, Roberson PL (2002) Comparison of MRI pulse sequences in defining prostate volume after permanent implantation. Int J Radiat Oncol Biol Phys 54:703-711
24. Deurloo E, Gilhuijs K, Schultze Kool L, Muller S (2001) Displacement of breast tissue and needle deviations during stereotactic procedures. Invest Radiol 36:347-353
25. Susil RC, Krieger A, Derbyshire JA, Tanacs A, Whitcomb LL, Fichtinger G, Atalar E (2003) System for MR image-guided prostate interventions: canine study. Radiology 228:886-894
26. Lindsay PE, Van Dyk J, Battista JJ (2003) A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation. Med Phys 30:1897-1908
27. Waterman FM, Yue N, Corn BW, Dicker AP (1998) Edema associatedwith I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys41:1069-1077
28. Waterman FM,DickerAP(2002) Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0? Int J Radiat Oncol Biol Phys 53:610-621
29. Vicini F, Vargas C, Gustafson G, Edmundson G, Martinez A (2003) High dose rate brachytherapy in the treatment of prostate cancer.World J Urol 21:220-228
30. Cormack RA, Kooy H, Tempany CM, D'Amico AV (2000) A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46:207-214
31. Todor DA, Cohen GN, Amols HI, Zaider M (2002) Operatorfree, film-based3Dseed reconstruction in brachytherapy. Phys Med Biol 47:2031-2048
32. Martin T, Baltas D, Kurek R, Roddiger S, Kontova M, Anagnostopoulos G, Dannenberg T, Buhleier T, Skazikis G, Tunn U, Zamboglou N (2004) 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 180:225-232
33. Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B (2001) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 50:1190-1198
34. Lee EK, Zaider M (2003) Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys 56:854-861
35. Wei Z, Wan G, Gardi L, Mills G, Downey D, Fenster A (2004) Robot-assisted 3D-TRUS guided prostate brachytherapy: system integration and validation. Med Phys 31:539-548
36. Burghardt E, Hofmann HMH, Ebner F, Haas J, Tamussino K, Justich E (1989) Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol 33:61-67
37. Greco A, Mason P, Leung AWL, Dische S, McIndoe GAJ, Anderson MC (1989) Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol 40:401-405
38. Christensen GE, Carlson B, Chao KS, Yin P, Grigsby PW, Nguyen K, Dempsey JF, Lerma FA, Bae KT, Vannier MW, Williamson JF (2001) Image-based dose planning of intracavitary brachytherapy: registration of serial-imaging studies using deformable anatomic templates. Int J Radiat Oncol Biol Phys 51:227-243
39. Eisbruch A,Williamson JF, Dickson R et al. (1993) Estimation of tissue volume irradiated by intracavitary implants. Int J Radiat Oncol Biol Phys 25:733-744
40. Brenner DJ, Huang Y, Hall EJ (1991) Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: equivalent regimens for combined brachytherapy and external irradiation. Int J Radiat Oncol Biol Phys 21:1415-1423
41. Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G (2001) Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 49:61-69
42. Kupelian PA, Reddy CA, Klein EA, Willoughby TR (2001) Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51:988-993
43. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R (2003) Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys 56:573-585
44. Low DA, Grigsby PW, Dempsey JF, Mutic S, Williamson JF, Markman J, Chao KS, Klein EE, Purdy JA (2002) Applicatorguided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 52:1400-1406
45. Wahab SH, MalyapaRS, Mutic S, Grigsby PW, Deasy JO, Miller TR, Zoberi I, Low DA (2004) A treatment planning study comparing HDR and AGIMRT for cervical cancer. Med Phys 31:734-743
46. Weeks KJ, Montana GS (1997) Three-dimensional applicator system for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 37:455-463
47. King CR, Lehmann J, Adler JR, Hai J (2003) CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2:25-30
48. Potters L, Cao Y, Calugaru E, Torre T, Fearn P,Wang XH (2001) A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50:605-614
49. Li X,Wang JZ, Amin PP, Earl M, Shepard D (2003) Using IMRT to repair unacceptable dose distributions of prostate implants. Int J Radiat Oncol Biol Phys 57:S434
50. Li XA,Wang JZ, Stewart RD, DiBiase SJ (2003) Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations. Phys Med Biol 48:2753-2765
51. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC (2002) Intensity-modulatedwhole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330-1337
52. Mundt AJ, Mell LK, Roeske JC (2003) Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity- modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56:1354-1360
53. Roeske JC, Bonta D, Mell LK, Lujan AE, MundtAJ (2003)Adosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69:201-207
54. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143
55. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, MaimanMA,Clarke- PearsonDL, Insalaco S (1999)Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153
56. Mutic S, Malyapa RS, Grigsby PW, Dehdashti F, Miller TR, Zoberi I, Bosch WR, Esthappan J, Low DA (2003) PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55:28-35
57. Schefter TE, Kavanagh BD,WuQ, Tong S, Newman F,McCourt S, Arnfield M, Benedict S,Mohan R (2002) Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim 27:177-184
58. Galalae RM, Martinez A, Mate T, Mitchell C, Edmundson G, Nuernberg N, Eulau S, Gustafson G, Gribble M, Kovacs G (2004) Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58:1048-1055
59. Galalae RM,Kovacs G, Schultze J, Loch T, Rzehak P,Wilhelm R, Bertermann H, Buschbeck B, Kohr P, Kimmig B (2002) Longtermoutcome after elective irradiationof the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52:81-90
60. Martinez AA, Gustafson G, Gonzalez J, Armour E, Mitchell C, Edmundson G, Spencer W, Stromberg J, Huang R, Vicini F (2002) Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radia Oncol Biol Phys 53:316-327
61. Wu Q, Arthur D, Benedict S, Tong S, Wu Y, Hagan M (2002) Intensity-modulated radiotherapy for prostate cancer treatment with nodal coverage. Int J Radiat Oncol Biol Phys54:321
62. Roach M III, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ,RotmanM, JonesC,AsbellSO,ValicentiRK,HanS,Thomas CR Jr et al. (2003) Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21:1904-1911
63. Wang JZ, Li XA (2003) Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 30:34-40
64. Niemierko A (1997) Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24:103-110
65. Niemierko A (1999) A generalized concept of equivalent uniform dose (EUD) (Abstract). Med Phys 26:1100
66. Lyman JT (1985) Complication probability as assessed from dose volume histograms. Radiat Res Suppl 104:S13-S19
67. Kutcher GJ, Burman C (1989) Calculation probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 16:1623-1630
68. Dale E, Hellebust TP, Skjonsberg A, Hogberg T, Olsen DR (2000) Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-ratebrachytherapyandexternalbeamradiotherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 47:963-971
69. Grigsby PW, Georgiou A, Williamson JF, Perez CA (1993) Anatomic variationof gynecologicbrachytherapyprescription points. Int J Radiat Oncol Biol Phys 27:725-729
70. Hellebust TP, Dale E, Skjonsberg A, Olsen DR (2001) Inter fraction variations in rectum and bladder volumes and dose distributionsduringhighdose ratebrachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 60:273-280
71. Hirose M, Bharatha A,Hata N, Zou KH,Warfield SK, Cormack RA, D'Amico A, Kikinis R, Jolesz FA, Tempany CM (2002) Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy Acad Radiol 9:906-912
72. Yue N, Dicker AP, Nath R, Waterman FM (1999) The impact of edema on planning 125I and 103Pd prostate implants. Med Phys 26:763-767
73. Thompson P (2002) A framework for computational anatomy. Comput Visual Sci 5:13-34
74. Bharatha A, Hirose M, Hata N, Warfield SK, Ferrant M, Zou KH, Suarez-Santana E, Ruiz-Alzola J, D'Amico A, Cormack RA, Kikinis R, Jolesz FA et al. (2001) Evaluation of threedimensional finite element-based deformable registration of pre- and intraoperative prostate imaging. Med Phys 28:2551-2560
75. Wu X,Dibiase SJ,GullapalliR, YuCX(2004) Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning. Int J Radiat Oncol Biol Phys 58:1577-1583
76. BrockKM,Balter JM,DawsonLA,KesslerML,MeyerCR(2003) Automated generationof a four- dimensionalmodel of the liver using warping and mutual information. Med Phys 30:1128-1133
77. JohnsHE, and CannighamJR (1983), The Physics of Radiology, 4th edition, Charles C. Thomas, Springfield, Ill.